0000805928-22-000013.txt : 20220217 0000805928-22-000013.hdr.sgml : 20220217 20220217161126 ACCESSION NUMBER: 0000805928-22-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220215 FILED AS OF DATE: 20220217 DATE AS OF CHANGE: 20220217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scopelianos Angelo CENTRAL INDEX KEY: 0001751541 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36046 FILM NUMBER: 22648179 MAIL ADDRESS: STREET 1: C/O AXOGEN, INC. STREET 2: 13631 PROGRESS BOULEVARD - SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axogen, Inc. CENTRAL INDEX KEY: 0000805928 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411301878 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: (386) 462-6817 MAIL ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 FORMER COMPANY: FORMER CONFORMED NAME: AxoGen, Inc. DATE OF NAME CHANGE: 20111004 FORMER COMPANY: FORMER CONFORMED NAME: LECTEC CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 wf-form4_164513225128430.xml FORM 4 X0306 4 2022-02-15 0 0000805928 Axogen, Inc. AXGN 0001751541 Scopelianos Angelo 13631 PROGRESS BOULEVARD SUITE 400 ALACHUA FL 32615 0 1 0 0 Chief R&D Officer Common Stock 2022-02-15 4 A 0 1325 0 A 12350 D Common Stock 2022-02-15 4 F 0 400 8.42 D 11950 D This reflects the number of shares that became vested as of February 15, 2022 upon the attainment of certain performance criteria. Includes 41 shares acquired under the Axogen stock purchase plan on December 31, 2021. The reported shares were sold, in compliance with company policy as to delivery of compensation based equity, with proceeds from such being used to cover the Reporting Person's tax withholding liability in connection with a portion of a performance stock award that vested on February 15, 2022. /s/ Angelo Scopelianos 2022-02-17